6 / 26
Page 42
Volume 3
August 5-6, 2019 | Singapore
CANCER RESEARCH AND PHARMACOLOGY
STRUCTURAL BIOCHEMISTRY, STEM CELLS AND MOLECULAR BIOLOGY
24
th
International Conference on
International Congress on
&
Cancer Research 2019 & Structural Biochemistry 2019
August 5-6, 2019
Journal of Cancer and Metastasis Research
Noninvasive methods of tumor detection and activity monitoring
Dmitry Malenkov
1
, A G Malenkov
1
, A S Botin
2
1
Scientific Center for Intergative Medicine, Russia
2
Sklifosovsky Institute of Emergency Medicine, Russia
T
he RTM device measures temperature in a tiny amount of tissue (approx. 1 cm3)
inside a body at depths up to 10 cm, with a precision of about 0.050C. A non-
invasive detector of the device measures tissue’s radiating heat within a spectrum of radio
waves. The method was licensed by the Ministry of Healthcare in 1997 for use in early
diagnosing of breast cancer, as well as for monitoring of this tumor during treatment
courses. Over observations confirmed that conclusions are true for most of locations
of cancer processes. Certain exceptions may only arise in cases of tumors in: kidneys,
stomach, pancreas, and liver. Due to a very high rate of thermo-production in these organs
areas of tumor heat may stay partially masked.
Ro-test. Immunology test was developed in P.A. Hertsen Moscow Oncology Research
Center in 1995. This test indicates products of metabolism of embryonic genes on
which wake up for activity while canceration. Numerous tests undertaken with a help
of about 100,000 patients suffering from different kinds of cancer revealed that Ro-test
gives up to 95% opportunity to reveal the existence of cancer of different locations and
origins. It occurs at times that the test reveals false positive results, when the anti-A-
serum accelerates sedimentation of red blood cells by more than 1.5 times (brink level
for positive canceration). Comparative later research together with the RTM test results, that we have been collecting here in our
Research Center for a couple of years, displays that in almost all these cases patients experienced a pre-cancer state at least in
one of the inner organs.
The combined approach of both techniques arms physicians with a perfect ongoing real-time tracking of the treatment process
and with means to define a stage of minimal metastasis risks, as well as to discover presence or absence of oncologic changes
after the surgery.
Biography
Dmitry Malenkov is now studying Public health management and Economics in Higher School of Economics. Surgeon, cardiothoracic
surgeon, oncologist, scientist, public health administrator, co-founder of Scientific center for integrative medicine. Dmitry Malenkov is
the author of more than 40 papers, in the field of clinical and experimental medicine
Andrey Malenkov spent over 50 years of his life to studying the mechanisms of tumor appearance and growth. He worked in laboratory
on cancerogenesis of Russian National Center of Oncology. Andrey Malenkov is the author of more than 80 papers, 20 books, a
scientific discovery and several patents in the field of oncology and natural sciences. Over 20 years Prof. Malenkov heads a medical
center for integrative oncology.
drmalenkov@gmail.com